Researcher profile
Miquel Bernardo
Affiliations
Organizations
Centre for Biomedical Network Research on Rare Diseasesauthorship · ESCentro de Investigación Biomédica en Red de Salud Mentalauthorship · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyerauthorship · ESHospital Clínic de Barcelonaauthorship · ESInstituto de Salud Carlos IIIauthorship · ESMedical Research Networkauthorship · USNeurosciences Instituteauthorship · USUniversidad de Oviedoauthorship · ESUniversitat de Barcelonaauthorship · ESUniversitat de Valènciaauthorship · ES
Public evidence
13 connected articles
Clusters of social and substance use-related risks are associated with the duration of untreated psychosis.2026 · Europe PMCMethylomic signature of current cannabis use in two first-episode psychosis cohorts.2025 · Europe PMCThe impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.2024 · Europe PMCThe Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study.2024 · Europe PMCCannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.2023 · Europe PMCFirst-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data2023 · PubMed Central Open AccessThe association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.2023 · Europe PMCCognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial.2022 · PubMed Central Open AccessDaily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.2021 · PubMed Central Open AccessThe continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.